Technology | December 18, 2012

Zoll Launches First Pediatric Electrodes That Report CPR Quality

Pediatric solution provides optimal support for resuscitation of children

December 18, 2012 — Zoll Medical Corp. announced that its new U.S. Food and Drug Administration (FDA)-cleared OneStep pediatric CPR electrodes are the only electrodes on the market with a built-in sensor that reports CPR quality on young children up to 8 years of age. The first-of-its-kind electrode provides optimal support for pediatric resuscitation when paired with the Zoll R Series monitor/defibrillator and CPR Dashboard.

The R Series offers extensive pediatric capabilities in a professional defibrillator with smart, simple and safe pediatric support. The OneStep pediatric CPR electrodes can be used for monitoring, pacing and defibrillation, as well as CPR.

“Too often, clinicians who treat children need to compromise and adapt devices designed for adults because there isn’t a pediatric version available,” said Jonathan Rennert, president of Zoll. “We recognize that the needs of children are different from adults and have provided a range of capabilities to support the special needs of the youngest patients.”

With the vast majority of pediatric arrests due to respiratory failure, the importance of high-quality CPR cannot be minimized. The 2010 American Heart Association (AHA) Guidelines place a heavy emphasis on quality CPR. Without a built-in CPR sensor, it’s difficult to judge how hard clinicians are pushing when performing CPR on a child. The FDA-cleared CPR Dashboard for the R Series reports the actual depth and rate of compressions delivered. A CPR timer gauges the CPR periods for optimal ventilation, while a metronome is activated if the rate falls below 100 compressions per minute. CPR data can be reviewed after the code and used for quality improvements.

In addition, Zoll’s See-Thru CPR, a proprietary filter that allows clinicians to see if an organized rhythm is developing during CPR, is also active with the pediatric CPR pads. See-Thru CPR helps to reduce the duration of interruptions to CPR and speeds time to shock when indicated.

In the event of a cardiac arrest, as soon as the pediatric electrodes are placed on the patient, the R Series immediately adjusts its AED analysis algorithm to pediatric parameters in order to reduce the likelihood that a compensating rhythm will be terminated. This ensures that any unique pediatric ECG morphology will be accurately identified when a shock is indicated.

The R Series is designed with a focus on simplicity to minimize errors and confusion. When the pediatric electrodes are attached to the R Series, the shock energy is automatically lowered to a starting dose of 50 joules. The R Series then measures the actual patient impedance and adjusts accordingly, delivering sufficient current for effective conversion while not delivering inaccurate energy to the child. The R Series can be configured to automatically lower the setting to whatever dose is desired, even as low as one joule.

For more information: www.zoll.com

Related Content

HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
iRhythm and Stanford Researchers Develop Deep Learning-Based Cardiac Arrhthymia Detection Algorithm
News | Artificial Intelligence| July 11, 2017
iRhythm Technologies Inc. announced a collaboration with the Stanford Machine Learning Group that has resulted in the...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
BioTrace Medical's Tempo Lead Shows Stability and Safety in Real-World Performance
News | Leads Implantable Devices| June 20, 2017
BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral presentation and...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Sponsored Content | Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Overlay Init